Literature DB >> 31628049

Distal Stent Graft Induced New Entry: Risk Factors in Acute and Chronic Type B Aortic Dissections.

Julia Lortz1, Felicitas Leinburger1, Konstantinos Tsagakis2, Christos Rammos1, Alexander Lind1, Thomas Schlosser3, Heinz Jakob2, Tienush Rassaf1, Rolf Alexander Jánosi4.   

Abstract

OBJECTIVES: Distal stent graft induced new entry (dSINE) is a rare complication associated with acute and chronic dissections after thoracic endovascular aortic repair (TEVAR) and is linked to a high re-intervention rate. The potential predicting risk factors for dSINE and long term outcome of patients after re-intervention were analysed.
METHODS: This single centre, retrospective study included patients undergoing TEVAR. Multivariable analysis was used to test important interventional parameters such as distal oversizing (dOS), taper ratio (TR), angle between distal stent graft and aorta, acute dissection and stent graft length. Re-intervention characteristics were analysed and further long term follow up after re-intervention were evaluated.
RESULTS: One hundred and eighty-five patients were analysed with acute (n = 77) and chronic (n = 108) dissections after TEVAR with an average follow up of 68.9 ± 32.5 months. During follow up, 12 (6.5%) patients developed dSINE after a median of 22.2 ± 20.7 months. Acute dissection was identified as a major predicting factor for dSINE development (15.8 fold increased odds), followed by increased dOS and TR. The re-intervention rate was higher in the dSINE group (83% vs. 20%, p = .001), but results indicated that no further re-intervention was needed and no new endoleak development occurred up to a mean follow up of 60.7 ± 54.8 months. No dSINE was seen in association with tapered stent grafts.
CONCLUSIONS: Acute aortic dissection was found to be the major predicting factor for dSINE development, followed by increased dOS and TR. The use of tapered stent grafts might be beneficial for patients with high expected dOS and TR. In the rare case of dSINE occurrence, even when re-intervention is required, the long term prognosis is good.
Copyright © 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Distal oversizing; Intravascular ultrasound; Stent graft induced new entry; Thoracic endovascular aortic repair

Mesh:

Year:  2019        PMID: 31628049     DOI: 10.1016/j.ejvs.2019.04.015

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  Hybrid Technique on the Total Arch Replacement for Type A Aortic Dissection: 12-year Clinical and Radiographical Outcomes From a Single Center.

Authors:  Bowen Zhang; Xiaogang Sun; Yanxiang Liu; Yaojun Dun; Shenghua Liang; Cuntao Yu; Xiangyang Qian; Haoyu Gao; Jie Ren; Luchen Wang; Sangyu Zhou
Journal:  Front Cardiovasc Med       Date:  2022-02-28

2.  Influence of measurement and sizing techniques in thoracic endovascular aortic repair on outcome in acute complicated type B aortic dissections.

Authors:  Miriam Rychla; Philip Dueppers; Lorenz Meuli; Zoran Rancic; Anna-Leonie Menges; Reinhard Kopp; Alexander Zimmermann; Benedikt Reutersberg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-03-31

3.  NEO E-vita-NEO era!

Authors:  Heinz Jakob; Fanar Mourad
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-01-19

4.  Preoperative systemic inflammatory response index predicts long-term outcomes in type B aortic dissection after endovascular repair.

Authors:  Yufei Zhao; Xiang Hong; Xinsheng Xie; Daqiao Guo; Bin Chen; Weiguo Fu; Lixin Wang
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

5.  Re-TEVAR in treatment of stent graft-induced new entry between two non-overlapping stent-grafts: a case report.

Authors:  Yiwei He; Shoujun Tang; Yongheng Zhang; Jianping Liu; Haining Zhou
Journal:  J Cardiothorac Surg       Date:  2020-10-15       Impact factor: 1.637

Review 6.  Role of Endoluminal Techniques in the Management of Chronic Type B Aortic Dissection.

Authors:  Konstantinos Spanos; Tilo Kölbel
Journal:  Cardiovasc Intervent Radiol       Date:  2020-06-29       Impact factor: 2.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.